Aktienkurs
29.88
Täglich Wechseln
-0.95 -3.08%
Monatlich
41.01%
Jährlich
41.28%
Q1 Prognose
28.98




Zahlungsmittel Und Äquivalente Veränderung Datum
Akebia Therapeutics USD 184.84M 18.4M 2025-12
Alnylam Pharmaceuticals USD 1.66B 167M 2025-12
Celltrion KRW 29.65B 799.42B 2025-06
Cspc Pharmaceutical CNY 7.57B 793.73M 2025-06
Deva Holding AS TRY 775.92M 574.67M 2023-09
Dianthus Therapeutics USD 51.09M 4.9M 2025-12
Divis Laboratories Ltd INR 4.15B 31.87B 2025-03
Gilead Sciences USD 7.33B 2.19B 2025-09
Ionis Pharmaceuticals USD 2.68B 437M 2025-12
Kangmei Pharma CNY 1.18B 278M 2025-09
Karyopharm Therapeutics USD 37.67M 1.05M 2025-09
Knight Therapeutics CAD 76.45M 5.43M 2025-12
Laboratorios Farma EUR 46.11M 18.92M 2025-06
MacroGenics USD 57.22M 22.91M 2025-12
Malin Corporation EUR 62.1M 26.4M 2024-12
Medical Developments International AUD 17.84M 219K 2025-06
Neuren Pharmaceuticals AUD 5.91M 2.76M 2025-06
Organigram Holdings CAD 7.58M 20.62M 2025-12
Pfizer USD 1.34B 295M 2025-09
Pharma Mar EUR 17.82M 3.78M 2025-12
Qiagen NV USD 1.36B 621.78M 2025-09
Roche Holding CHF 7.55B 579M 2025-06
Sangamo BioSciences USD 38.34M 13.16M 2025-06
Sanofi EUR 7.66B 1.25B 2025-12
Sarepta Therapeutics USD 801.28M 188.2M 2025-12
Sartorius EUR 389.9M 429.1M 2025-09
Sino Biopharmaceutical CNY 3.38B 2.09B 2024-12
Takeda JPY 654.94B 26.55B 2025-12
Tilray USD 264.83M 43.16M 2025-06
Zealand Pharma A/S 4.58B 1.4B 2025-12
Zz Pientze Pharmaceu CNY 1.77B 376.03M 2025-06